The researchers eliminated endogenous DAB2IP from a metastatic prostate cancer cell line using the shRNA-lentiviral system and performed Western blot analysis to confirm the loss of DAB2IP protein 6 Following this study, in 2012, Yu L et al. The gene discussed is DAB2IP; the disease is prostate carcinoma.